Sangamo Therapeutics, Inc. SGMO Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sangamo Therapeutics, Inc. SGMO

SGMO 0.530

+7.5%

Dec 4 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (16)	4/10/2000 2:00:00 PM
From: loonalone	Read Replies (3) of 368

Does anyody with scientific background on this thread have an explanation of if (and if so, and how) Aria's ARGENT and RAPIDcompete/don't compete with SGMO's ZFP regulation technology? Is this a marketing/positioning/partnering space or is it a pure patent space? Is there a biological explanation for whether or not there may or may not be competing platforms? Need to know. Thanks.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next